Trials / Completed
CompletedNCT02005159
Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae
Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST and Pharmacokinetic/Pharmacodynamic) in Prognosis of Bacteremia by Enterobacteriaceae
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,064 (actual)
- Sponsor
- Fundación Pública Andaluza Progreso y Salud · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
Provide scientific and validated data to help International Authorities to set susceptible to antibiotics cut-off points in bacteremia by Enterobacteriaceae
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Microbiological studies |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-12-09
- Last updated
- 2015-08-07
Locations
14 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02005159. Inclusion in this directory is not an endorsement.